The clinical outcome and treatment in Behçet's disease with deep vein thrombosis.
Akdağ Köse
Afet
A
Dermatology Department, Istanbul Medical School, Istanbul, Turkey.
Kayabali
Murat
M
Sarica
Rifkiye
R
Kaymaz
Rukoye
R
Azizlerli
Gülsevim
G
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications / Q000628:therapy*; D003078:Colchicine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D013927:Thrombosis / Q000150:complications / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D003078:Colchicine